Azithromycin to Reduce Mortality

The authors emphasize the lifesaving benefits of azithromycin demonstrated in the AVENIR trial, which showed a 14% reduction in child mortality in Niger. Concerns about antimicrobial resistance should not hinder access to this critical intervention, and stewardship programs should instead be implemented to monitor resistance without creating barriers to drug availability.